Deal Library / Pharma BD Deal Intelligence

Cephalon Inc. — Pharma Deals

The Pharma Closeout tracks 13 deals, $6.5B in disclosed deal value, 13 with a post-close Outcome Score for Cephalon Inc..

Median Critic Score: 80  ·  Median Outcome Score: 63

Best outcome: Cephalon Inc. / Laboratoire L. Lafon S.A. (Group Lafon) (89)  ·  Weakest outcome: Cephalon Inc. / Mesoblast Limited (19)

All 13 deals

• Cephalon Inc. / Salmedix, Inc. — 2005 · $160M · Worked — the deal delivered on its rationale.
• Cephalon Inc. / Laboratoire L. Lafon S.A. (Group Lafon) — 2000 · $450M · Worked — the deal delivered on its rationale.
• Cephalon Inc. / Group Lafon (France) — 2001 · $450M · Worked — the deal delivered on its rationale.
• Cephalon Inc. / Cell Therapeutics, Inc. — 2005 · $70M · Largely worked — most objectives met.
• Cephalon Inc. / Anesta Corp. — 2001 · $444M · Largely worked — most objectives met.
• Cephalon Inc. / Anesta Corp. — 2000 · $444M · Largely worked — most objectives met.
• Cephalon Inc. / Zeneus Holdings Limited (Zeneus Pharma) — 2005 · $360M · Largely worked — most objectives met.
• Cephalon Inc. / CIMA Labs Inc. — 2003 · $515M · Mixed — partial payoff, real shortfalls.
• Cephalon Inc. / CIMA Labs Inc. — 2004 · $515M · Mixed — partial payoff, real shortfalls.
• Cephalon Inc. / Mepha AG — 2010 · $615M · Did not work — the deal failed to deliver.
• Cephalon Inc. / Ception Therapeutics — 2010 · $250M · Did not work — the deal failed to deliver.
• Cephalon Inc. / Arana Therapeutics Limited — 2009 · $203M · Did not work — the deal failed to deliver.
• Cephalon Inc. / Mesoblast Limited — 2010 · $2.0B · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals